A.la cultura del Imperio Romano
B.la invasión del pueblo germano
C.la cultura musulmana/árabe
D.la cultura cristiana tradicional
第1题
【C1】
A.spreading
B.expanding
C.extending
D.stretching
第2题
If such pills catch on, they could generate significant revenues for drug companies. In Pfizer's case, the goal is to transfer as many qualified patients as possible to the combo pill. Norvase's patents expire in 2007, but Pfizer could avoid losing all its revenues from the drug at once if it were part of a superpill. Sena Lund, an analyst at Cathay Financial, sees Pfizer selling $4.2 billion worth of Norvasc-Lipitor by 2007. That would help take up the slack for falling sales of Lipitor, which he projects will drop to $5 billion in 2007, down from $8 billion last year.
Pfizer argues that addressing two distinct and serious cardiovascular risk factors in one pill has advantages. People with both hypertension and high LDL cholesterol (the "bad" kind) number around 27 million in the U.S., notes Craig Hopkinson, medical director for dual therapy at Pfizer, and only 2% of that population reaches adequate treatment goals. Taking two treatments in one will increase the number of patients who take the medications properly and "assist in getting patients to goal," he says.
Doctors also may be quick to adopt Norvasc-Lipitor, Pfizer figures, because it's made up of two well-studied drugs, which many physicians are already familiar with. But Dr. Stanley Rockson, chief of consultative cardiology at Stanford University Medical Center, says fixed-dose combination pills represent "an interesting crossroads" for physicians, who are typically trained to "approach each individual problem with care." Combining treatments would challenge doctors to approach heart disease differently. But better patient compliance is important enough, says Rockson, that he expects doctors to be open to trying the combined pill.
Some other physicians are more skeptical. "If you want to change dosage on one of the new pill's two drugs, you're stuck," fears Dr. Irene Gavris, professor of medicine at Boston University School of Medicine. She says she would feel most comfortable trying the combination pill on patients who "have been on the drugs for a while" and are thus unlikely to need changes in dosage.
As usual, economics could tip the scales. Patients now taking both Lipitor and Norvasc "could cut their insurance co-pay in half" by switching to the combo drug, Gavris notes. That's a key advantage. Controlling hypertension, for instance, can require three or more drugs, and the financial burden on patients mounts quickly. If patients also benefit—as Pfizer and other drug companies contend—making the switch to superpills could be advantageous for everyone.
Pfizer could avoid the loss caused by expiration of Norvasc's patents by______.
A.reducing the various risks to heart health
B.switching the patients to the superpills
C.offering greater convenience to patients
D.increasing the sales of Lipitor
第3题
If such pills catch on, they could generate significant revenues for drug companies. In Pfizer's ease, the goal is to transfer as many qualified patients as possible to the combo pill. Norvasc's patents expire in 2007, but Pfizer could avoid losing all its revenues from the drug at once if it were part of a superpill. Sena Lund, an analyst at Cathay Financial, sees Pfizer selling $4.2 billion worth of Norvasc-Lipitor by 2007. That would help take up the slack for falling sales of Lipitor, which he projects will drop to $5 billion in 2007, down from $8 billion last year.
Pfizer argues that addressing two distinct and serious cardiovascular risk factors in one pill has advantages. People with both hypertension and high LDL cholesterol (the "bad" kind) number around 27 million in the U.S., notes Craig Hopkinson, medical director for dual therapy at Pfizer, and only 2% of that population reaches adequate treatment goals. Taking two treatments in one will increase the number of patients who take the medications properly and "assist in getting patients to goal", be says.
Doctors also may be quick to adopt Norvasc-Lipitor, Pfizer figures, because it's made up of two well-studied drugs, which many physicians are already familiar with. But Dr. Stanley Rockson, chief of consultative cardiology at Stanford University Medical Center, says fixed-dose combination pills represent "an interesting crossroads" for physicians, who are typically trained to "approach each individual problem with care". Combining treatments would challenge doctors to approach heart disease differently. But better patient compliance is important enough, says Rockson, that he expects doctors, to be open to trying the combined pill.
Some other physicians are more skeptical. "If you want to change dosage on one of the new pill's two drugs, you're stuck", fears Dr. Irene Gavris, professor of medicine at Boston University School of Medicine. She says she would feel most comfortable trying the combination pill on patients who "have been on the drugs for a while" and are thus unlikely to need changes in dosage.
As usual, economics could tip the scales. Patients now taking both Lipitor and Norvasc "could cut their insurance co pay in half" by switching to the combo drug, Gavris notes. That's a key advantage. Controlling hypertension, for instance, can require three or more drugs, and the financial burden on patients mounts quickly. If patients also benefit—as Pfizer and other drug companies contend—making the switch to superpills could be advantageous for everyone.
Pfizer could avoid the loss caused by expiration of Norvasc's patents by ______.
A.reducing the various risks to heart health
B.switching the patients to the superpills
C.offering greater convenience to patients
D.increasing the sales of Lipitor
第4题
A.Multicultural teams often generate frustrating management dilemmas.
B.Cultural differences can create substantial obstacles to effective teamwork—but these may be subtle and difficult to recognize until significant damage has already been done.
C.Cultural challenges are manageable if managers and team members choose the right strategy and avoid imposing single-culture-based approaches on multicultural situations.
D.The differences between direct and indirect communication can’t cause serious damage to relationships when team projects run into problems.
第5题
regulate corporate governance were futile because of differences in national culture. He drew particular attention to
the Organisation for Economic Co-operation and Development (OECD) and International Corporate Governance
Network (ICGN) codes, saying that they were, ‘silly attempts to harmonise practice’. He said that in some countries,
for example, there were ‘family reasons’ for making the chairman and chief executive the same person. In other
countries, he said, the separation of these roles seemed to work. Another delegate, Alliya Yongvanich, said that the
roles of chief executive and chairman should always be separated because of what she called ‘accountability to
shareholders’.
One delegate, Vincent Viola, said that the right approach was to allow each country to set up its own corporate
governance provisions. He said that it was suitable for some countries to produce and abide by their own ‘very
structured’ corporate governance provisions, but in some other parts of the world, the local culture was to allow what
he called, ‘local interpretation of the rules’. He said that some cultures valued highly structured governance systems
while others do not care as much.
Required:
(a) Explain the roles of the chairman in corporate governance. (5 marks)
第6题
第7题
A.Multiculturalism might become a war of all against all.
B.Islamic and other immigrants will become liberals in Holland.
C.Group identity should be maintained in multiculturalism.
D.Multiculturalism fails to exist in Europ
第8题
【C1】
A.commonality
B.status
C.uniqueness
D.locate
第9题
【M1】
第10题
Schlesinger addresses the questions: What holds a nation together? And what does it mean to be an American? Describing the emerging cult of ethnicity, Schlesinger praises its healthy effect on a nation long shamed by a history of prejudice and narrow-mindedness. But he warns against the campaign of multicultural advocates to divide the nation into separate ethnic and racial communities. From the start, he observes, the United States has been a multicultural nation, rich in its diversity but held together by a shared commitment to the democratic process and by the freedom of intermarriage. It was this national talent for assimilation that impressed foreign visitors like Alexis de Tocqueyille and James Bryce, and it is this historic goal that Schlesinger champions as the best hope for the future. Schlesinger analyzes what he sees as grim consequences of identity politics: the widening of differences. Attacks on the First Amendment, he argues, threaten intellectual freedom and, ultimately, the future of the ethnic groups. His criticisms are not limited to the left. As a former target of McCarthyism, be understands that the radical right is even more willing than the radical left to re strict and weaken the Bill of Rights.
The author does not minimize the injustices concealed by the "melting pot" dream. The Disuniting of America is both academic and personal, forceful in argument, balanced in judgment. It is a book that will no doubt anger some readers, but it will surely make all of them think again. The winner of Pulitzer Prizes for history and for biography, an authoritative voice of American liberalism, Schlesinger is uniquely positioned to bring bold answers and healing wisdom to this passionate debate over who we are and what we should become.
According to Schlesinger, the United States is ______.
A.a melting pot
B.a nation with diverse cultures held together by the democratic process
C.a federation of ethnic and racial communities
D.a nation with various ethnic and racial groups
为了保护您的账号安全,请在“上学吧”公众号进行验证,点击“官网服务”-“账号验证”后输入验证码“”完成验证,验证成功后方可继续查看答案!